共 85 条
- [1] Berguli L.(1994)Cyclosporin A in the treatment of B-chronic lymphocytic leukemia (B-CLL) Leukemia 8 1245-1246
- [2] Gregoretti M. G.(1986)Chemotherapy of brain tumors: physiological and pharmacokinetic considerations Semin. Oncol. 13 70-82
- [3] Caligaris-Cappio F.(1994)Development of vincristine resistance and increased sensitivity to cyclosporin A and verapamil in the human U-937 lymphoma cell line without overexpression of the 170-kDa P-glycoprotein Int. J. Cancer. 58 269-274
- [4] Blasberg R. G.(1987)Evaluation of a tetrazolium-based semiautomated colorimetric assay; assessment of radiosensitivity Cancer. Res. 47 936-942
- [5] Groothuis D. R.(1983)Comparison of postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas Cancer 52 997-1007
- [6] Botling J.(1988)Flowcytometric determination of modal DNA population in relation to proliferative potential of human intracranial neoplasms J. Neurosurg. 69 588-592
- [7] Liminga G.(1995)Cyclosporin A is a substance P (tachykinin NK1) receptor antagonist Eur. J. Pharmacol. 26 289-289
- [8] Larsson R.(1972)Malignant glioma of the brain stem: a clinicopathological analysis of 13 cases J. Neurol. Neurosurg. Psychiarty. 35 732-738
- [9] Nygren P.(1993)Protein kinase C inhibitor suppress cell growth in established and low-passage glioma cell lines. A comparison between stausporine and tamoxifen Neurosurgery 33 495-501
- [10] Nilsson K.(1992)Chemotherapy of gliomas Curr. Opin. Lipidol. 5 526-533